trial · primary record
4SCAR DLL3 T cells
Glioblastoma of Cerebellum
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2028-12-31 |
| Primary endpoint | Number of patients with adverse events. |
| Registry ID | NCT07180927 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:03.438Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07180927
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.